Skip to content

Clinical trials

Brain Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Country / region: South Korea Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20111
20121
20131
20142
20161
20172
20182
20202
20223
20232
20242
20254
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Terminated7
Completed5
Active, not recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca3
Samsung Medical Center3
Eli Lilly and Company2
GlaxoSmithKline2
Seoul National University Hospital2
TauRx Therapeutics Ltd2
AbbVie1
Advanced Technology & Communications1
Bristol-Myers Squibb1
Duk Lyul Na1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases25
Alzheimer Disease15
Central Nervous System Diseases15
Nervous System Diseases15
Dementia14
Neurodegenerative Diseases12
Mental Disorders10
Neurocognitive Disorders8
Tauopathies7
Cognitive Dysfunction3

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.